Benitec Biopharma Inc. ( BNTC) - Stock Earnings
BNTC Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 13, 2026, midnight | — / — | — | — / — | — |
BNTC Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -11.8 million USD | — USD |
| 2026Q1 | -11.9 million USD | — USD |
| 2026Q2 | -12.8 million USD | -833044 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
BNTC Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | -21.8 million USD | 216000 USD |
| 2025 | -37.9 million USD | — USD |
| 2026 | -45.5 million USD | — USD |
| 2026 Est. | — | — |
BNTC
Price: $8.63
52 week price:
Earnings Per Share: -0.98 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 208500
Ebitda: -11.8 millionMarket Capitalization: 319.3 million